Correlation Between Fate Therapeutics and NRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and NRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and NRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and NRx Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and NRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of NRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and NRx Pharmaceuticals.
Diversification Opportunities for Fate Therapeutics and NRx Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fate and NRx is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and NRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NRx Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with NRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NRx Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and NRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fate Therapeutics and NRx Pharmaceuticals
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the NRx Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Fate Therapeutics is 1.25 times less risky than NRx Pharmaceuticals. The stock trades about -0.24 of its potential returns per unit of risk. The NRx Pharmaceuticals is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 5.29 in NRx Pharmaceuticals on September 27, 2024 and sell it today you would earn a total of 1.71 from holding NRx Pharmaceuticals or generate 32.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 90.91% |
Values | Daily Returns |
Fate Therapeutics vs. NRx Pharmaceuticals
Performance |
Timeline |
Fate Therapeutics |
NRx Pharmaceuticals |
Fate Therapeutics and NRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and NRx Pharmaceuticals
The main advantage of trading using opposite Fate Therapeutics and NRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, NRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRx Pharmaceuticals will offset losses from the drop in NRx Pharmaceuticals' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
NRx Pharmaceuticals vs. Fate Therapeutics | NRx Pharmaceuticals vs. Caribou Biosciences | NRx Pharmaceuticals vs. Karyopharm Therapeutics | NRx Pharmaceuticals vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |